VALUE CHAIN INSIGHTS

VALUE CHAIN INSIGHTS

  • Posted in: Value Chain Insights

    This year thus far has seen several high-profile deals and expansion moves in the contract development and manufacturing ...

  • Posted in: Value Chain Insights

    Biomanufacturing is a leading area of investment for the pharmaceutical majors. So what are the leading projects announced, ...

  • Posted in: Value Chain Insights

    Kåre Schultz, now president and CEO of H. Lundbeck A/S, has been appointed president and CEO of Teva Pharmaceutical Industries. ...

  • Posted in: Value Chain Insights

     The oncology sector is the largest therapeutic sector in the pharmaceutical industry. So what is in store for the global ...

  • Posted in: Value Chain Insights

    Batch processing is the historical and dominant form of manufacturing in the pharmaceutical industry, but continuous ...

  • Posted in: Value Chain Insights

    Thermo Fisher Scientific has completed its $7.2-billion acquisition of Patheon. So what is the impact for Thermo, Patheon, ...

  • Posted in: Value Chain Insights

    Although the future of healthcare reform is unclear, debates on drug pricing continue. So what should be on the radar ...